Form 4: Praxis CFO Sells Shares for Tax Obligations

Praxis Precision Medicines' CFO, Timothy Edwin Kelly, reported the disposition of 943 common shares to cover tax liabilities from vested restricted stock units.

Summary

• Timothy Edwin Kelly, Chief Financial Officer of Praxis Precision Medicines, Inc. (PRAX), reported a transaction on January 12, 2026.
• The transaction involved the disposition of 943 shares of Common Stock.
• These shares were withheld by the Issuer to satisfy tax withholding obligations related to the vesting of previously reported restricted stock units.
• The shares were disposed of at a price of $275.74 per share.
• Following this transaction, Timothy Edwin Kelly beneficially owns 31,046 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposition of shares for tax purposes, which is a neutral event regarding the company's operational performance or future outlook.

Future Outlook

NA

Industry Context

This is a routine insider transaction common across all industries where executives receive equity compensation. The disposition of shares for tax withholding is a standard practice when restricted stock units vest, and does not typically reflect a discretionary investment decision by the insider.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence in the company.

Key Dates

Keywords

Praxis Precision Medicines, PRAX, Form 4, Insider Transaction, CFO, Stock Sale, Tax Withholding, Equity Compensation